ribociclib
novartis
['bcsm', 'breast', ' ribo', 'ribociclib']
addition of ribociclib to endocrine therapy provides idfs benefit in hr+/her2 early breast cancer #asco2023 #asco23 #bcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.